Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Stock Has Consensus Price Target of $9.81 According to Analysts

Shares of Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) have been given a consensus rating of “Moderate Buy” by the six research firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $9.81.

Several research analysts have recently weighed in on EVLV shares. TD Cowen reaffirmed a “buy” rating and set a $10.00 target price on shares of Evolv Technologies in a research note on Tuesday, June 9th. Craig Hallum reissued a “buy” rating and issued a $11.25 price target on shares of Evolv Technologies in a research note on Wednesday, August 12th. LADENBURG THALM/SH SH began coverage on shares of Evolv Technologies in a report on Tuesday, September 8th. They issued a “buy” rating and a $8.00 price target for the company. Wall Street Zen upgraded shares of Evolv Technologies from a “sell” rating to a “hold” rating in a research report on Sunday, August 30th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Evolv Technologies in a research report on Tuesday.

Evolv Technologies Price Performance

NASDAQ:EVLV opened at $4.57 on Thursday. Evolv Technologies has a 52 week low of $4.56 and a 52 week high of $8.81. The company has a quick ratio of 1.11, a current ratio of 1.18 and a debt-to-equity ratio of 0.24. The stock has a market capitalization of $827.76 million, a PE ratio of -152.33 and a beta of 1.75. The stock’s 50-day moving average price is $5.27 and its 200-day moving average price is $5.80.

Evolv Technologies (NASDAQ:EVLV) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.02). The business had revenue of $43.75 million during the quarter, compared to analyst estimates of $41.80 million. Evolv Technologies had a negative return on equity of 4.53% and a negative net margin of 3.05%. As a group, equities analysts expect that Evolv Technologies will post -0.2 EPS for the current fiscal year.

Insider Activity at Evolv Technologies

In related news, Director Richard Shapiro bought 19,100 shares of the business’s stock in a transaction dated Friday, September 4th. The stock was acquired at an average price of $4.96 per share, with a total value of $94,736.00. Following the completion of the purchase, the director directly owned 39,000 shares of the company’s stock, valued at approximately $193,440. This trade represents a 95.98% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. 5.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Evolv Technologies

Several institutional investors have recently bought and sold shares of EVLV. Stoic Point Capital Management LLC lifted its position in shares of Evolv Technologies by 1.4% in the first quarter. Stoic Point Capital Management LLC now owns 5,765,507 shares of the company’s stock valued at $34,881,000 after acquiring an additional 77,751 shares in the last quarter. Emerald Advisers LLC increased its position in shares of Evolv Technologies by 3.9% during the first quarter. Emerald Advisers LLC now owns 4,333,055 shares of the company’s stock worth $26,215,000 after purchasing an additional 161,812 shares in the last quarter. Emerald Mutual Fund Advisers Trust increased its position in shares of Evolv Technologies by 6.6% during the first quarter. Emerald Mutual Fund Advisers Trust now owns 2,667,589 shares of the company’s stock worth $16,139,000 after purchasing an additional 165,100 shares in the last quarter. BNP Paribas Financial Markets raised its stake in Evolv Technologies by 118.5% in the 4th quarter. BNP Paribas Financial Markets now owns 1,407,644 shares of the company’s stock valued at $10,079,000 after purchasing an additional 763,412 shares during the last quarter. Finally, Peregrine Capital Management LLC acquired a new position in Evolv Technologies in the 1st quarter valued at $9,722,000. 66.65% of the stock is currently owned by institutional investors and hedge funds.

About Evolv Technologies

Evolv Technologies develops artificial intelligence-powered security screening systems designed to detect weapons and other threats while allowing people to move through checkpoints without routinely removing personal belongings. Its technology is intended to help security teams improve protection and reduce congestion compared with traditional screening methods.

The company’s primary products include Evolv Express, a touchless weapons-detection system, and Evolv Insights, a software platform that provides operational data and analytics to help organizations manage screening programs.